ArticleFrontiers in oncology2025

MiR-424-5p acts as an oncogene in Hep3B cells by activating the PI3K/AKT signaling pathway.

Zhixian Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.